Moderna Inc (NASDAQ: MRNA) on Friday, soared 9.21% from the previous trading day, before settling in for the closing price of $30.95. Within the past 52 weeks, MRNA’s price has moved between $22.28 and $48.92.
A company in the Healthcare sector has dropped its sales by -42.94% annually for the last half of the decade. The company achieved an average annual earnings per share of 13.49%. With a float of $357.38 million, this company’s outstanding shares have now reached $391.00 million.
Moderna Inc (MRNA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Moderna Inc is 8.54%, while institutional ownership is 70.21%. The most recent insider transaction that took place on Dec 11 ’25, was worth 703,306. In this transaction Director of this company sold 23,853 shares at a rate of $29.48, taking the stock ownership to the 3,924 shares. Before that another transaction happened on Dec 11 ’25, when Company’s Affiliate proposed sale 23,853 for $29.49, making the entire transaction worth $703,306.
Moderna Inc (MRNA) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -2.91 earnings per share (EPS) for the period falling under the consensus outlook (set at -2.76) by -0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.80% during the next five years compared to -42.94% drop over the previous five years of trading.
Moderna Inc (NASDAQ: MRNA) Trading Performance Indicators
Moderna Inc (MRNA) is currently performing well based on its current performance indicators. A quick ratio of 3.73 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.06, a number that is poised to hit -2.63 in the next quarter and is forecasted to reach -6.76 in one year’s time.
Technical Analysis of Moderna Inc (MRNA)
Let’s dig in a bit further. During the last 5-days, its volume was 13.1 million. That was better than the volume of 10.92 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 83.78%.
During the past 100 days, Moderna Inc’s (MRNA) raw stochastic average was set at 96.24%, which indicates a significant increase from 95.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.44 in the past 14 days, which was higher than the 1.31 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.44, while its 200-day Moving Average is $27.51. However, in the short run, Moderna Inc’s stock first resistance to watch stands at $34.98. Second resistance stands at $36.15. The third major resistance level sits at $38.06. If the price goes on to break the first support level at $31.90, it is likely to go to the next support level at $29.99. Assuming the price breaks the second support level, the third support level stands at $28.82.
Moderna Inc (NASDAQ: MRNA) Key Stats
Market capitalization of the company is 13.21 billion based on 390,734K outstanding shares. Right now, sales total 3,236 M and income totals -3,561 M. The company made 1,016 M in profit during its latest quarter, and -200,000 K in sales during its previous quarter.
